Evidence map›Paper›PMID 32528969›Full record

ArticleFrontiers in medicine2020

An Update in Drug-Induced Thrombotic Microangiopathy.

Thomas Chatzikonstantinou, Maria Gavriilaki, Achilles Anagnostopoulos, Eleni Gavriilaki

Abstract read
In one paragraph

Article in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Monoclonal Gammopathy of Thrombotic Significance.American journal of hematology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Post-transplant Thrombotic Microangiopathy.Journal of the American Society of Nephrology : JASN · 2025
    Review
  8. Article
  9. Article
  10. Frontiers in pharmacology · 2025
    Article
  11. Article
  12. The Phenomenon of Thrombotic Microangiopathy in Cancer Patients.International journal of molecular sciences · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thomas ChatzikonstantinouBMT Unit, Hematology Department, G Papanicolaou Hospital, Thessaloniki, Greece.
Maria GavriilakiLaboratory of Clinical Neurophysiology, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Achilles AnagnostopoulosBMT Unit, Hematology Department, G Papanicolaou Hospital, Thessaloniki, Greece.
Eleni GavriilakiBMT Unit, Hematology Department, G Papanicolaou Hospital, Thessaloniki, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

drughematologyneurologyoncologythrombotic microangiopathy

Identifiers

PMID32528969
PMCPMC7256484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.